MedPath

Surgical Versus Medical Treatment of Acromegaly

Completed
Conditions
Acromegaly
Registration Number
NCT01000090
Lead Sponsor
University of Aarhus
Brief Summary

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
63
Inclusion Criteria
  • Acromegaly diagnosis
  • treated with Somatostatin analogues or surgery
  • in treatment control
Exclusion Criteria
  • treatment with GH-antagonist
  • never treated
  • not in treatment control

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Århus University Hospital, Medical department M

🇩🇰

Århus, Denmark

© Copyright 2025. All Rights Reserved by MedPath